Improving Latent Tuberculosis (TB) Diagnosis in Thai Children
NCT00947609 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 158
Last updated 2012-06-06
Summary
The study is a prospective study to improve the diagnosis and management of latent TB in HIV-infected and HIV uninfected children in Thailand. The objectives are to assess the sensitivity and specificity of IGRAs (T-Spot®.TB, a T-cell-based assay, and QuantiFERON®-TB Gold In-tube, a whole blood assay), TST, and a refined symptom-based questionnaire in diagnosing latent TB in 166 HIV-infected and HIV uninfected children in Thailand, and to evaluate the influence of age, nutritional and immune status on children's response to the IGRAs. These children will be screened for TB with a detailed TB contact history, symptom-based questionnaire, physical examination, TST, chest radiograph (and abdominal ultrasound for those with abdominal symptoms), IGRAs, and clinical specimens for acid fast bacilli stain and culture. A diagnostic algorithm will be generated using the combination of test modalities with the highest sensitivity and specificity results.
Conditions
- Latent Tuberculosis
- HIV Infections
Sponsors & Collaborators
- collaborator OTHER
-
New York Blood Center
collaborator OTHER -
HIV Netherlands Australia Thailand Research Collaboration
collaborator NETWORK -
Queen Sirikit National Institute of Child Health
collaborator OTHER_GOV -
SEARCH Research Foundation
lead OTHER
Principal Investigators
-
Jintanat Ananworanich, MD, PhD · South East Asia Research Collaboration with Hawaii, HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand
-
Piyarat Suntarattiwong, MD · Queen Sirikit National Institute of Child Health, Bangkok, Thailand
-
Simon Tsiouris, MD, MPH · Columbia University
Eligibility
- Min Age
- 2 Months
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-08-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Thailand
Study Locations
More Related Trials
-
Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT
NCT00647205 ·Status: COMPLETED ·Phase: PHASE4
-
Diagnosis of Tuberculosis Infection in HIV Co-infected Children
NCT00541294 ·Status: COMPLETED
-
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
NCT06113861 ·Status: RECRUITING
-
A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV
NCT07124559 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
NCT01622140 ·Status: COMPLETED
-
QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
NCT01223534 ·Status: COMPLETED ·Phase: PHASE4
-
Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa
NCT02119130 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TB
NCT01099098 ·Status: COMPLETED
-
Improved Diagnostics for Paediatric Tuberculosis
NCT06944561 ·Status: COMPLETED ·Phase: NA
-
Diagnosis of Active and Latent TB Infection With IFN-y Assays in African Children
NCT00456469 ·Status: UNKNOWN
-
Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan
NCT02208427 ·Status: UNKNOWN ·Phase: PHASE3
-
A Multicentre, Cohort Study of Screening and Preventive Intervention for Latent Tuberculosis Infection in Children
NCT04156568 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis
NCT05586230 ·Status: COMPLETED ·Phase: PHASE1
-
Infant TB Infection Prevention Study
NCT02613169 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
NCT00931736 ·Status: COMPLETED ·Phase: PHASE3
-
TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts
NCT06022146 ·Status: RECRUITING ·Phase: PHASE3
-
Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers
NCT00311220 ·Status: UNKNOWN ·Phase: PHASE4
-
Promoting Adherence to TB Regimens in Latino Adolescents
NCT00005738 ·Status: COMPLETED
-
Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits
NCT00804713 ·Status: COMPLETED ·Phase: NA
-
Shortened Regimen for Drug-susceptible TB in Children
NCT06253715 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Analysis of Safety in Latent Tuberculosis Infection Prophylaxis Treatment
NCT04655794 ·Status: UNKNOWN
-
Predictive Values of Next Generation Interferon Gamma Release Assays for Latent Tuberculosis Infection
NCT02512939 ·Status: COMPLETED ·Phase: NA
-
Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)
NCT05989802 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Four Stool Processing Methods Combined With Xpert MTB/RIF Ultra for Diagnosis of Intrathoracic Paediatric TB (TB-Speed - Stool Processing)
NCT04203628 ·Status: COMPLETED ·Phase: NA
-
Shorter and Safer Treatment Regimens for Latent TB
NCT06498414 ·Status: RECRUITING ·Phase: PHASE2/PHASE3